Detail Terapi medikamentosa diabetes mellitus tipe 2 terkini Bibliografi Author: WIDYAMISHALOCA, MARIA ; ROSALI, ALEXANDER ; Makimian, S.Robby (Advisor); Iryaningrum, Maria Riastuti (Advisor) Topik: diabetes mellitus type 2; kencing manis; penyakit gula Bahasa: (ID )     Penerbit: Fakultas Kedokteran Unika Atma Jaya     Tempat Terbit: Jakarta Utara    Tahun Terbit: 2009     Jenis: Theses - Karya Tulis Ilmiah Kedokteran (KTI-FK) Ketersediaan Perpustakaan FK Nomor Panggil: KTI-FK-51 Non-tandon: tidak ada Tandon: 1  Lihat Detail Induk Abstract Diabetes Mellitus (DM) is a group of metabolic diseases with characteristic hyperglycemia that occurs due to the abnormal secretion of insulin, and/or insulin resistance. DM is divided into two major classifications of the DM type 1 and type 2 Diabetes. DM type 1 occurs in the absence of insulin. While the type 2 Diabetes occurs because insulin is not used as expected (insulin resistance). Although the prevalence of DM type 1 and type 2 increases worldwide, the prevalence of type 2 Diabetes increased more rapidly than type 1. This is because the increase in obesity and reduced activity that occurs in society and this is a risk factor for type 2 Diabetes. Both the research to find the appropriate and accurate address to prevent complications in people with type 2 Diabetes. Studies conducted primarily in the search for effective medical treatment in the blood glucose control. There are two categories of drugs most recent Glucagon-like group Antidiabetik Peptide-1 Receptor agonist (Agonist GLP - 1) and the Dipeptidyl-peptidase-IV group Inhibitors (inhibitors DPP-IV). The works of GLP-1 Agonists are the same as inkretin GLP-1, a hormone that produced by the pancreas to stimulate insulin secretion. Meanwhile, DPP-IV Inhibitors work by slowing the inactivation inkretin hormone GLP-1 and GIP (Glucose-dependent Insulinotropic Polypeptide), so the hormone can stimulate insulin inkretin spending again. The use of the lastest oral antidiabetic medication for people with Diabetes type 2 needs more further validity test, because although drugs proved controlling blood sugar type 2 Diabetes, but not yet published results of research on the bad effects occur in the use of new medicines. Opini Anda Klik untuk menuliskan opini Anda tentang koleksi ini! Lihat Sejarah Pengadaan  Konversi Metadata   Kembali

Copyright © 2006, 2007 Unika Atma Jaya, all rights reserved